Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.

MLA

Rosenthal, Eben L., et al. “Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 21, no. 16, Aug. 2015, pp. 3658–66. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-14-3284.

APA

Rosenthal, E. L., Warram, J. M., de Boer, E., Chung, T. K., Korb, M. L., Brandwein-Gensler, M., Strong, T. V., Schmalbach, C. E., Morlandt, A. B., Agarwal, G., Hartman, Y. E., Carroll, W. R., Richman, J. S., Clemons, L. K., Nabell, L. M., & Zinn, K. R. (2015). Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 21(16), 3658–3666. https://doi.org/10.1158/1078-0432.CCR-14-3284

Chicago

Rosenthal, Eben L, Jason M Warram, Esther de Boer, Thomas K Chung, Melissa L Korb, Margie Brandwein-Gensler, Theresa V Strong, et al. 2015. “Safety and Tumor Specificity of Cetuximab-IRDye800 for Surgical Navigation in Head and Neck Cancer.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 21 (16): 3658–66. doi:10.1158/1078-0432.CCR-14-3284.